Skip to main content
SpringerLink
Log in

Calcium modifies the accumulation and retention of daunorubicin by Ehrlich ascites carcinoma

  • Short Communication
  • Daunorubicin
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Verapamil restores daunorubicin sensitivity to daunorubicin resistant Ehrlich ascites carcinoma but is without effect when used with daunorubicin in daunorubicin sensitive parental Ehrlich ascites tumor. Energy dependent daunorubicin efflux is more active in drug resistant than in drug sensitive cells. However, daunorubicin retention decreases equivalently in drug resistant and sensitive cells with increasing calcium levels in the presence of both intact and interrupted outward transport. Therefore, (1) daunorubicin accumulation and retention in Ehrlich ascites carcinoma cells is influenced by at least two independent mechanisms and (2) it is likely that verapamil modifies daunorubicin activity in drug resistant tumor variants by mechanisms beyond calcium inhibition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Skovsgaard T (1978) Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells. Cancer Res 38:4722–4727

    PubMed  Google Scholar 

  2. Slater LM, Murray SL, Wetzel MW, Wisdom RM, Du Vall EM (1982) Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma. J Clin Invest 70:1131–1134

    PubMed  Google Scholar 

  3. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967–1972

    PubMed  Google Scholar 

  4. Tsuruo T, Iida H, Yamashiro M, Tsukagoshi S, Sakurai Y (1982) Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin. Biochem Pharmacol 31:3138–3140

    Article  PubMed  Google Scholar 

  5. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1983) Potentiation of vincristine and adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors. Cancer Res 43:2267–2272

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, College of Medicine, University of California, Irvine, 92717, Irvine, CA, USA

    Sandra L. Murray, Emily M. Du Vall & Lewis M. Slater

Authors
  1. Sandra L. Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emily M. Du Vall
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lewis M. Slater
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murray, S.L., Du Vall, E.M. & Slater, L.M. Calcium modifies the accumulation and retention of daunorubicin by Ehrlich ascites carcinoma. Cancer Chemother. Pharmacol. 13, 69–70 (1984). https://doi.org/10.1007/BF00401452

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00401452

Keywords

Search

Navigation